Evidence map›Paper›PMID 35388105›Full record

ArticleScientific reports2022

Towards automation of the polyol process for the synthesis of silver nanoparticles.

Jakob B Wolf, Tomasz M Stawski, Glen J Smales, Andreas F Thünemann, Franziska Emmerling

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Silver-Based Surface Plasmon Sensors: Fabrication and Applications.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jakob B WolfFederal Institute for Materials Research and Testing (BAM), 12489, Berlin, Germany.ORCID 0000-0003-0201-2745
Tomasz M StawskiFederal Institute for Materials Research and Testing (BAM), 12489, Berlin, Germany. tomasz.stawski@bam.de.ORCID 0000-0002-0881-5808
Glen J SmalesFederal Institute for Materials Research and Testing (BAM), 12489, Berlin, Germany.ORCID 0000-0002-8654-9867
Andreas F ThünemannFederal Institute for Materials Research and Testing (BAM), 12489, Berlin, Germany.ORCID 0000-0002-9883-6134
Franziska EmmerlingFederal Institute for Materials Research and Testing (BAM), 12489, Berlin, Germany. franziska.emmerling@bam.de.ORCID 0000-0001-8528-0301

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metal nanoparticles have a substantial impact across different fields of science, such as photochemistry, energy conversion, and medicine. Among the commonly used nanoparticles, silver nanoparticles are of special interest due to their antibacterial properties and applications in sensing and catalysis. However, many of the methods used to synthesize silver nanoparticles often do not result in well-defined products, the main obstacles being high polydispersity or a lack of particle size tunability. We describe an automated approach to on-demand synthesis of adjustable particles with mean radii of 3 and 5 nm using the polyol route. The polyol process is a promising route for silver nanoparticles e.g., to be used as reference materials. We characterised the as-synthesized nanoparticles using small-angle X-ray scattering, dynamic light scattering and further methods, showing that automated synthesis can yield colloids with reproducible and tuneable properties.

Indexed as

Metal NanoparticlesSilverAnti-Bacterial AgentsAutomationParticle SizePolymersAnti-Bacterial AgentsPolymerspolyolSilver

Identifiers

PMID35388105
PMCPMC8986771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.